Please visit answersincme.com/YXX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatrics discusses respiratory syncytial virus (RSV) vaccines for infants. Upon completion of this activity, participants should be better able to: Recognize the rationale for considering respiratory syncytial virus (RSV) vaccines for infants; Describe the clinical profiles of emerging long-acting monoclonal antibodies and maternal vaccines for preventing RSV in infants; and Outline strategies for optimal integration of emerging agents, including overcoming barriers to vaccination, for improving patient outcomes.